Delivery Order SPE2DB22D3016-SPE2DB24FBFP4

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,366.28 firm-fixed-price delivery order is for the supply of STELARA 45 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999, to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $21,371.16 firm-fixed-price contract is for the supply of 4,565,371,847 units of the specialty medication STELARA (45 mg/0.5 mL syringe). The award has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,798.59, is for the supply of 4568202268 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,746.33, is for the provision of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The order has an ultimate completion date of February 16, 2024 and utilizes a firm fixed price pricing structure. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,440.38 firm fixed-price contract is for the supply of 4562519452 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award has an ultimate completion date of October 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,208.38 firm fixed-price contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of January 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $34,377.14 firm-fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The order has a completion date of July 31, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4565924194 units of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a firm fixed price of $14,682.03 and an ultimate completion date of September 25, 2024. There is no set-aside designation for this award. AmerisourceBergen, one of the largest pharmaceutical distributors in the United...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,061.08, is for the procurement of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,869.48, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor, and there are no set-aside requirements mentioned. This...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFP4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $14,247.44, is for the supply of 4565634369 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies to provide a wide range of critical medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 11/28/24, 9:02 AM